RHB Initiates ‘Buy’ on iFast on Rising Asia-Pacific Wealth Management Demand
RHB has initiated a “buy” rating on iFast, setting a target price of S$12.20 (≈$9.00) – a 36.7% upside from the recent close of S$8.94 (≈$6.60). The broker highlights the rapid expansion of Asia‑Pacific wealth management, projected to reach $41.8 trillion by 2031, and iFast’s asset‑light model that can scale assets under administration with minimal cost. RHB forecasts profit‑before‑tax margins rising to 39‑42% by FY2028 and AUA growth at a 22% CAGR, driven by its ePension business and a profitable digital‑banking arm that posted $1.16 billion in digital deposits in FY2025. Risks include earnings dependence on AUA, regulatory changes and foreign‑exchange exposure.
Three Profitable Indian Stocks for Long-Term Growth
The Ashoka India Equity Investment Trust highlights three core holdings—Bharti Airtel, ICICI Bank and Bajaj Finserv—as its top long‑term profit drivers. Each company combines strong return‑on‑capital metrics with attractive valuations, positioning them to capture growth in India's telecom, banking and diversified...
REITs Boosted by UK Property Renaissance
UK REITs like Picton Property Income and Custodian Property Income are benefiting from a quiet property market upturn, delivering positive total returns of 6.7% last year. Picton's £405 million ($514 million) REIT, focused on industrial and retail assets, posted a 4.9% yield...
Graphene-Info Releases a New Edition of Its Graphene Investment Guide
Graphene-Info has released a new edition of its Graphene Investment Guide, updating financial data and market analysis for public graphene companies. The guide notes that despite ongoing revenue challenges, most covered firms have seen share price gains over the past...
Terrestrial Energy Inc (IMSR) Q4 2025 Earnings Call Transcript
Terex Corp completed its merger with REV Group, creating a standalone specialty vehicles segment and targeting $75 million of annual run‑rate synergies, half of which are expected within the next twelve months. The company delivered 2025 earnings per share of...
Nakamoto Inc (NAKA) Q4 2025 Earnings Call Transcript
Nasdaq (NASDAQ) reported full‑year 2025 net revenue of $5.2 billion, up 12% YoY, with solutions revenue surpassing $4 billion. Operating income rose 16% to $2.9 billion, delivering a 56% operating margin and a 24% increase in diluted EPS. The company achieved record index...
How Much Higher Can DigitalOcean Stock Go?
DigitalOcean (DOCN) is leveraging its SMB‑focused cloud platform to capture booming AI demand, reporting an 18% ARR increase to $970 million in 2025 and a 150% surge in AI‑related revenue. The company announced an $800 million capital raise to expand AI‑optimized data...
Analysts Remain Bullish on SailPoint. (SAIL) Amid Strong Q4 and Full-Year Results
SailPoint (NASDAQ:SAIL) posted a strong fiscal 2026, with total ARR climbing 28% to $1.125 billion and SaaS ARR jumping 38% to $746 million. Fourth‑quarter revenue rose 23% to $295 million, delivering $61 million of adjusted operating income and $57 million of free cash flow. The...
Near a 15-Year Low, Is This 6.6%-Yielding Stock Too Cheap to Ignore or a Value Trap?
General Mills (GIS) slumped to a 52‑week low on March 24, its lowest level in 15 years, pushing the dividend yield to 6.6%—one of the highest in the S&P 500. The company projects a modest 1.5‑2% drop in full‑year organic net sales and...
PetroChina Successfully Concludes "the 14th Five-Year Plan", 2025 Operating Results Remain at Historical High Levels
PetroChina reported 2025 revenue of ¥2.86 trillion (≈$401 bn) and profit attributable of ¥157.3 billion (≈$22 bn), despite a 14.6% drop in Brent prices. Free cash flow rose 15.2% to ¥120.2 billion (≈$16.8 bn) and the debt‑to‑asset ratio improved to 36.4%. The company paid a record...
Jefferies Initiates Vor Biopharma Stock with Buy Rating on Autoimmune Pivot
Jefferies has initiated coverage of Vor Biopharma with a buy rating and a $50 price target, far above the current $14.48 share price. The company recently pivoted to autoimmune diseases, licensing telitacicept for lupus, rheumatoid arthritis, and myasthenia gravis, and...
JPMorgan Upgrades HDFC Bank Stock Rating on Valuation Appeal
JPMorgan upgraded HDFC Bank to Overweight, lowering its price target to INR 1,010 (about $12.2). The bank’s shares have fallen 33% YTD, trading at a 16‑year low price‑to‑book of 1.5× and a $24.35 price near its 52‑week low. The rating lift...
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1325860496-80ae2abedee74880a6699e0883e202f2.jpg)
ROA Vs. ROE: Understanding Key Financial Health Metrics
The article clarifies the distinction between return on equity (ROE) and return on assets (ROA) as essential gauges of a company’s financial health. It uses the fictional Ed’s Carpets case to illustrate a 23.8% ROE versus a modest 0.85% ROA,...
Top Wall Street Analysts Like These Dividend Stocks for Solid Returns
Wall Street analysts highlighted three dividend‑paying stocks—Diamondback Energy, Crescent Energy, and Darden Restaurants—as attractive amid market volatility. Diamondback offers a 2% yield and a projected 22% total return, while Crescent provides a 3.5% yield after a $3.1 billion acquisition. Darden delivers...
This Chinese Gold Play Is Attractive Even as the Metal Sees Big Price Swings, Analysts Say
Laopu Gold, a Hong Kong‑listed Chinese jewelry maker, posted first‑quarter net profit of roughly $521 million, a 160% total‑return surge despite a 20% drop in gold prices to $4,098 per ounce. JPMorgan upgraded the stock to overweight with a price target...
Entergy: Meta Deal Exemplifies Its Strong Growth Profile (Rating Downgrade)
Entergy’s shares have surged more than 30% over the past year as data‑center demand fuels a robust capital‑expenditure cycle. The company secured a power‑purchase agreement with Meta that adds 5.2 GW of new capacity while transferring construction risk to the tech...
Rexford: Finding A Good Valuation For Very Little Or No Growth
Rexford Industrial Realty (REXR) now trades at a 5.36% dividend yield and a historically low price‑to‑AFFO multiple, reflecting sharply rebased growth expectations. The firm’s AFFO is projected to expand only 1.66% per year through 2028, with recent guidance hinting at...
UPS CFO Issues Stark Warning to Dividend Investors
UPS CFO Brian Dykes announced the company will freeze its dividend in 2026, ending expectations of a raise. The logistics giant is currently paying out 80%‑90% of net income, well above its long‑term 50%‑60% target. A sharp reduction in Amazon‑related...
BME: Removal Of Option Writing Can Improve NAV Growth (Rating Upgrade)
BlackRock Health Sciences Trust (BME) received a Buy rating upgrade as it drops its option‑writing program and pivots to a pure equity strategy. The change is expected to boost net asset value (NAV) growth while preserving an 8.3% monthly dividend...
Fabrinet: Excellent Growth Is Overshadowed By Overvaluation And Overbought Stock Level
Fabrinet posted record Q2 2026 results, with revenue climbing 36% year‑over‑year to $1.13 billion and non‑GAAP earnings per share rising 29% to $3.36. The growth stems from expanded capacity, robust demand in telecom and high‑performance computing, and a balance sheet free of...
The Market Is Cracking - I'm Getting Ready To Buy My Favorite Stocks
The strategist warns that the market’s recent crack‑down is creating a rare dislocation, presenting a window to acquire high‑quality, pricing‑power stocks. While macro headwinds such as stagflation and higher rates linger, the analysis points to a shift toward value‑oriented equities...
Russell 2000 Stocks: Too Early or Finally Interesting?
The Russell 2000 trades at about 19‑times earnings, well below the S&P 500’s 27‑times multiple, leaving a roughly 50 % valuation gap. With the Federal Reserve signaling no near‑term rate cuts, small‑cap stocks remain volatile but could benefit from any easing....
When Stock Markets Are Rattled, Even by War, It Usually Pays for Investors to Be Patient
U.S. equities have historically rebounded from every major correction, including wars and financial crises, and the S&P 500 remains about 8.7% below its early‑year peak after a fifth consecutive losing week. The ongoing Iran‑related conflict has pushed oil to $119 per...
Affirm: A Solid Footing or More Volatility Ahead?
Affirm Holdings posted a strong Q2, with gross merchandise volume climbing 36% to $13.8 billion and revenue rising 30% to $1.12 billion, while net income surged 61% to $130 million. The company expanded its merchant network to 478,000 partners and grew its active...
SA Asks: What's the Most Attractive Space Stock Right Now?
Elon Musk’s SpaceX is preparing what could become the largest IPO in history, prompting investors to look for alternative space equities. Seeking Alpha analysts Oakoff Investments and Michael Del Monte highlight Rocket Lab (RKLB) and Firefly Aerospace (FLY) as the most attractive...
Asian Paints, Berger Paints, Dabur, HUL, TCS : Are the Famed Consistent Compounders in for a Lost Decade?
The article examines how Indian stalwarts such as Asian Paints, HUL, TCS, Dabur and others—once hailed as "consistent compounders"—have delivered dismal total returns over the past six years, lagging far behind the Nifty 50’s 10.6% CAGR. While these firms still...
Why This PSU General Insurer’s Shares Can Be Accumulated on Dips Now
New India Assurance (NIACL), India’s largest PSU general insurer, has slipped 43% from its 52‑week high, now trading around ₹121.85 (~$1.47) per share, or 0.9 × its trailing book value, giving a market‑cap of roughly $2.4 billion. The stock is 25% below...
These NPS Schemes Weathered the 18-Month Market Pain
Over the 18‑month market downturn from September 2024 to March 2026, National Pension System (NPS) equity schemes declined 9.3%, outperforming the Nifty 100 (‑11%) and large‑cap mutual funds (‑9.7%). Corporate‑bond NPS schemes posted a solid 10.2% gain, beating the CRISIL Composite index’s 8.1%...
TDIV: Tech's Value Proposition Has Improved With The Sell-Off
First Trust NASDAQ Technology Dividend Index Fund (TDIV) slipped about 5% amid broader tech volatility, but its valuation gap to the S&P 500 has essentially vanished, bringing its price‑to‑earnings ratio in line with the broader market. The fund’s dividend per share rose 16% year‑over‑year in...
COWZ: Makes It Easy To Navigate Market Selloffs
The Pacer US Cash Cows 100 ETF (COWZ) targets defensive investors by focusing on large‑cap firms with high free‑cash‑flow yields, currently offering a 2% yield and strong dividend‑growth prospects. Its dynamic sector allocation and disciplined rebalancing helped it capture only...
KRE: Valuations Are Declining, But May Not Correct Soon
The State Street SPDR S&P Regional Banking ETF (KRE) is rated Hold as it trades at deep value with an average PE of 10.77 and price‑to‑book of 1.1. However, the fund’s constituents carry heavy commercial‑real‑estate exposure—many have over 50% of...
Anthropic Struggling with Chinese Competition, Its Own Safety Obsession
Anthropic, fresh from a $30 billion funding round and a public‑safety stance, is eyeing an IPO in Q4 2026. The company’s financials show $5 billion in revenue against $10 billion spent on inference and training, widening its cash‑burn gap. Meanwhile, Chinese AI firms now...
Dividend Resilience: Why These Kings Are Safe After a Volatile Q1
The article spotlights three Dividend Kings—Procter & Gamble, Colgate‑Palmolive, and Hormel Foods—as reliable income generators amid the volatile first quarter of 2026. Each company boasts strong balance sheets, sustainable payout ratios, and defensive business models that have supported consecutive dividend...
Buffett’s Zurich Acolyte Says Odds of Beating Market Keep Fading
Guy Spier, the Zurich‑based founder of the $470 million Aquamarine Fund, announced the fund’s closure after his brain‑cancer relapse and a prolonged streak of underperformance. He argues that artificial‑intelligence tools have leveled the research playing field, making traditional Buffett‑style stock picking increasingly...
Hermès: In An AI World Flooded With Abundance, Scarcity May Become Even More Valuable
Hermès remains a rarity‑driven luxury asset, sustaining premium valuations despite recent macro‑related sell‑offs. In 2025 the company posted $18 billion in revenue and an impressive 41.75 % operating margin, underscoring the power of its scarcity model. A current ratio near five and...
Goldman Sachs’ India Bets Slide in FY26; 5 Stocks Crash over 50% but One Turns Multibagger
Goldman Sachs’ India equity portfolio shrank 36% in FY 26, dropping from roughly $1.44 billion to about $916 million. The decline was driven by five major holdings—Laxmi Dental, Awfis, Newgen, Aurionpro and Ganesha—each losing more than 50%. Conversely, six stocks posted gains between 20%...
Summit Hotel Properties: Undervalued With High Yield Make This A Buy
Summit Hotel Properties (INN) has been reaffirmed as a Buy, driven by a robust balance sheet, a 7.46% dividend yield and a deep valuation discount. The company holds $240 million in liquidity, no debt maturities until 2028, and 77% of its...
I Was So Wrong About Upstart: Do Not Ignore The AI Threat
Upstart (UPST) was downgraded to a sell as analysts cite stagnant margins, heightened macro uncertainty, and accelerating AI‑driven competition. The company posted a strong 35% year‑over‑year revenue increase and modestly beat guidance, but margin contraction and limited upside to its...
IVE: Recent Outperformance Is Unsustainable
The iShares S&P 500 Value ETF (IVE) has been downgraded to a Hold as its recent outperformance is tied to fleeting, event‑driven factors. Gains stemmed from a heavy energy tilt and an under‑weight in mega‑cap tech, both of which are losing...
SCHG: Excellent High-Quality Growth ETF Comes With Big Short-Term Risks
The Schwab US Large‑Cap Growth ETF (SCHG) manages roughly $49 billion with a low 0.04% expense ratio and holds about 200 high‑quality stocks. While its long‑term track record is strong and it captures the quality factor premium, the fund is down...
Here's How Much $100 Invested In FormFactor 10 Years Ago Would Be Worth Today
FormFactor (NASDAQ: FORM) delivered a 29.68% average annual return over the past decade, outpacing the broader market by 17.76% on a yearly basis. The company’s market capitalization now sits at roughly $7.63 billion. A $100 investment made ten years ago would...
What Is an Exchange Fund? Investment Benefits and Risks
Exchange funds, also called swap funds, let high‑net‑worth investors exchange a large, concentrated stock position for a diversified basket of equities without triggering an immediate capital‑gains tax. The vehicle is a private partnership managed by banks or wealth‑management firms and...
More than Half of the S&P 500 Industry Sectors Are in Correction Territory. How Much Longer Until the Index Itself...
The S&P 500 is edging toward correction after a sharp March decline, with more than half of its industry groups already in correction territory. The Dow Jones Industrial Average slipped into correction on Friday, followed a day earlier by the Nasdaq Composite....
Here’s What You Need to Know About Denison Mines (DNN)’s Q4 2025 Earnings
Denison Mines Corp. posted Q4 2025 revenue of $899,530, up 10.43% year‑over‑year and $96,510 above estimates, while earnings per share slipped to a loss of $0.02, missing consensus by $0.01. CEO David Cates announced that the Phoenix ISR uranium mine secured...
This TSX Stock Was a Top Gainer on the Week with a 40% Upside Possible Based on Its Growing Market...
BRP Inc., the maker of Sea‑Doo and Ski‑Doo, posted earnings that highlighted new product rollouts, a 12% year‑over‑year gain in North American market share, and inventory positioned in a "healthy spot," sending the stock up about 9% for the week....
GUT Is Good, But XLU Is Better
The Gabelli Utilities Trust (GUT) is a solid defensive option but falls short of the Utilities Select Sector SPDR Fund (XLU) in risk‑adjusted performance. While GUT offers a slightly higher yield and total return, its higher expense ratio and greater...
2 Stocks I Plan to Hold for the Next 20 Years
The article recommends holding two healthcare stocks—Johnson & Johnson (JNJ) and Vertex Pharmaceuticals (VRTX)—for the next 20 years. It highlights JNJ’s diversified drug and device portfolio, dividend‑king status, top‑tier credit rating, and wide moat that protect it from patent cliffs....
While the S&P 500 Falls, This $7 Stock Quietly Looks Like a Steal
SoundHound AI’s shares have slumped 71% since October, trading below $7, while the company’s revenue doubled in 2025 and it secured over 100 new contracts in Q4. The AI voice‑assistant firm remains cash‑rich with $248 million on hand and no debt,...
Rising Treasury Yields Are Spooking Investors: Should Buy-and-Hold Investors Care?
The 10‑Year Treasury yield, which peaked above 5% in late 2023, has rebounded to roughly 4.4% after a dip to 3.8% in August 2024, reflecting lingering inflation and geopolitical risks. The Federal Reserve has held rates steady this year, but...
EPS: A Quality ETF Based On An Earnings-Weighted Approach, But A Hold For Now
WisdomTree U.S. Large‑Cap ETF (EPS) employs an earnings‑weighted approach that tilts toward mega‑cap technology and communication services, giving the fund a quality‑growth profile. The ETF trades at roughly a 10% price‑to‑earnings discount to the Russell 1000, reflecting its high‑margin, high‑growth holdings....